Free Online Seminar. Endometrial Cancer: Understanding Biomarker Testing and Its Value in the Changing Treatment Landscape

Join us Wednesday, April 9, 2025, for a FREE online seminar to learn about the importance of genetics and biomarkers on the treatment of endometrial cancer. 

This comprehensive program will cover essential topics including the difference between genetics and biomarkers, what tests are most effective in understanding treatment options, which testing is needed at diagnosis vs. recurrence, and more.

Expert speakers from the field of gynecologic oncology will lead the discussions, sharing their research findings, new developments, and treatment options.

Participants will have the opportunity to ask questions during a live Q&A session and seek clarification on various treatment options and recent medical developments. This no-cost event aims to empower you with knowledge and support, enhancing your treatment journey. Register here.

This event is made possible with support from AstraZeneca.

OCRA Now Accepting Letters of Intent for 2026 Research Grants

Deadline: March 26 at 5PM ET

2026 grant funding opportunities for $100,000 to $900,000 are now available for projects focusing on ovarian cancer and/or related gynecologic cancer, being conducted at educational institutions or non-profit scientific research facilities. OCRA’s grants are open to international researchers. Letters of Intent are due Wednesday, March 26, 2025, at 5:00 PM Eastern. Learn more and apply.

OCRA’s Advocate’s Corner

Three OCRA Advocates have a conversation in front of U.S. Capitol Building
OCRA Advocates at 2023 Fall Advocacy Day

New administrations inevitably bring changes, both big and small. The top priority of OCRA’s Policy & Advocacy team remains the same–ensuring the voices of the ovarian and gynecologic cancer community are heard and the issues that impact our community are considered. Read this month’s Advocate’s Corner.

OCRA Names Winners of Two Prizes in Recognition of Notable Research

Dr. David Gershenson, Dr. Zihua Gong

Dr. David M. Gershenson of MD Anderson Cancer Center has been awarded the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research in recognition of his groundbreaking discoveries in the field of rare ovarian cancers.

Dr. Zihua Gong of Cleveland Clinic has been awarded the Liz Tilberis Research Prize for Outstanding Early Career Investigators for his work to advance knowledge of BRCA-mutant ovarian cancer. Learn more.

New Support Sessions

Cindy, with her creation from “Embracing Your Inner Monster” session of Staying Connected: Express Yourself

Book Club: Heaven and Earth Grocery Store, by James McBride
March 11th at 3pm
Register here.

Express Yourself: Colorful Creations
March 20th at 3pm
Register here.

12-Week Session: Giving Voice to Grief
April 2nd — June 18
Wednesdays from 7pm – 8:00pm

This program will focus on understanding the grieving process, coping with the reality of grief, learning to adjust to life after loss, and finding ways to continue to honor and live with and without your loved one. Register here.

Ways to Give

Turn your favorite activity into a fundraiser to help those impacted by ovarian and all gynecologic cancers.

You can help further our mission by hosting an event or creating a virtual campaign to benefit OCRA’s research grants, advocacy initiatives and support programs for survivors and their families.

Become an OCRA Hero today.